Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies

Technology appraisal guidance
Reference number: TA171
Published: 18 June 2009
Last updated: 26 June 2019

Appendix A: GE Decision paper

Appendix A: GE Decision paper

Appendix A: GE Decision paper
13 November 2010
(74.29 Kb 21 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 November 2012